For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

This is an exciting and rewarding time to begin a career in biomedical research. The pace of scientific discovery is breathtaking. Endless opportunities exist for our graduates as they begin their careers.

Extraordinary research opportunities are available within the Department of Microbiology and Immunology and collaborative research units including the Division of Infectious Disease and HIV Medicine in the areas of:

  • Immunology
  • Molecular and human genetics
  • Virology
  • Malarial and bacterial pathogenesis
  • Emerging disease and biodefense
  • Opportunistic infections
  • Experimental therapeutics and diagnostics
  • Neuroscience
  • Cancer biology

Continued advances in technology and collaborative interdisciplinary research between basic and clinical scientists will be the key to innovation and new discovery in the next decade. Research conducted within the department will be of tremendous importance to the growing national and international health care needs.

We are committed to understanding molecular mechanisms of infectious diseases within the human population and the development of strategies to prevent and/or treat these acute, chronic, and latent infectious diseases.

The research programs of our faculty are funded by the National Institute of Allergy and Infectious Disease, National Institute of Neurological Disorders and Stroke, National Cancer Institute, National Institute of Child Health and Human Development, National Institute of General Medical Science and the National Multiple Sclerosis Society.

For more information on individual faculty members, their research interests, and training opportunities offered by our outstanding faculty, please explore the department's web page through the links at the left.

Meet Our Faculty - Joris Beld, PhD

Joris Beld, PhD "My lab is interested in natural products. In other words, we're interested in molecules that we get from nature. If you go to a hospital and you look at the list of drugs they prescribe to patients, you'll find that roughly 75 percent of those are derived from natural products. Those drugs are not something that chemists have invented. They're made from molecules that we've borrowed from nature."

Read more from Dr. Beld

News and Announcements

Suresh G. Joshi, MD, PhD, is Recognized and Elected as Fellow to Infectious Diseases Society

The nation’s leading infectious diseases professional society, the Infectious Diseases Society of America (IDSA), recognizes the distinguished physicians and scientists from the United States and around the world, and the board of directors elects them as fellows to IDSA. This fellowship honors those nationals and internationals that have achieved professional excellence and provided significant service to the profession through practice, education, mentoring and research in infectious diseases, medical microbiology and public health. On August 10, 2016, Dr. Joshi’s contribution over the past 28 years and the services rendered in this field has been recognized by IDSA. Dr. Joshi is director of the Center for Surgical Infection & Biofilm at the Institute for Molecular Medicine and Infectious Diseases, and he is an adjunct professor at the A.J. Drexel Plasma Institute, as well as Drexel's School of Biomedical Engineering, Science & Health Systems.

"New Drug Could Treat Parkinson's"

More than 6 million people suffer from Parkinson's disease worldwide, and that number is predicted to double by the year 2030. Current treatment with L-dopa drugs leaves much to be desired. Most patients — as many as 80 percent — who take L-dopa drugs develop dyskinesia, a painful involuntary movement disorder, within five years.
Pulse (Fall 2015)

Upcoming Events

In the Media

"How to Check for Ticks"
Related Faculty: Garth Ehrlich, PhD
KYW-TV (CBS-3) (May 24, 2016)

"The Death-Knell of Malaria Parasites: Too Much Cholesterol"
Related Faculty: Akhil Vaidya, PhD
Philly Voice (May 26, 2016)

Brian Wigdahl, PhD, Chair, Microbiology and Immunology; Director, Institute for Molecular Medicine and Infectious Disease

Brian Wigdahl, PhD
Chair, Microbiology and Immunology; Director, Institute for Molecular Medicine and Infectious Disease